Is Nurix Therapeutics, Inc. (NRIX) a Buy, Sell, or Hold?
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$22.98 USD
$0.27 (1.19%)
- Volume
- 1.57M
- Average Volume
- 1.97M
- Market Capitalization
- $1.99B
- P/E Ratio
- -6.66
- Dividend Yield
- 0.00%
- Price Target
- $34.00
- Year High
- $25.09
- Year Low
- $8.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.34
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-32.4% DOWNSIDE
$34.00 Price Target
UPSIDE/DOWNSIDE HIGH
-48.9% DOWNSIDE
$45.00 Price Target High
UPSIDE/DOWNSIDE LOW
-0.1% DOWNSIDE
$23.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Mizuho Securities | Joseph Catanzaro | $34 | $23.06 | 2026-07-13 06:43 AM | 47.4% |
| Truist Financial | Gregory Renza | $34 | $23.0472 | 2026-07-10 08:41 AM | 47.5% |
| UBS | David Dai | $23 | $15.07 | 2026-06-09 09:30 AM | 52.6% |
| BTIG | Jeet Mukherjee | $32 | $15.64 | 2026-06-09 07:19 AM | 104.6% |
| Jefferies | Roger Song | $45 | $15.56 | 2026-06-08 01:25 PM | 189.2% |